Professor of Medical microbial pathogenesis at the Department of Medical Biochemistry and Biophysics since 2008.
Researchers in medical microbial pathogenesis study how microbes, primarily bacteria, cause disease. The research covers the interaction between bacteria and the infected person's immune defence, how the disease can be diagnosed and how it should be treated.
A central issue in Birgitta Agerberth's research is how the inherited immune defence manages to keep us healthy despite all the bacteria around us. More precisely, it revolves around the human antimicrobial peptide LL-37 and how it works and is regulated, with the current focus on shigella.